Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

University of British Columbia

$17,500.00

Patterns of antipsychotic utilization in individuals with treatment-resistant psychosis

EF 2015-16

Résumé
Antipsychotics are commonly prescribed for the treatment of schizophrenia and other psychotic disorders. Unfortunately, adequate trials of these drugs are not always effective in alleviating symptoms. This is problematic because the remission of psychosis is necessary for recovery. Therefore, the optimization of existing treatments is the first step towards improving the quality of life in individuals with treatment-resistant psychosis.Clozapine is the most effective antipsychotic in treatment-resistant psychosis. However, some of its adverse effects have contributed to its underutilization in clinical practice. Other treatment strategies are commonly used despite their lack of evidence. Suffice it to say, the management of treatment-resistant psychosis is a challenging endeavor that is all too often based on clinical experience rather than empirical evidence.The proposed research looks to build upon existing evidence in the pharmacological management of treatment-resistant psychosis. Thus, the objectives are 1) to characterize the patterns of antipsychotic utilization on admission to and discharge from the BC Psychosis Program, 2) to investigate the outcomes associated with the different patterns of antipsychotic utilization, and 3) to determine if these patterns and outcomes differ with the sex and diagnosis of the treated individual. The hope is that these findings will inform future research and clinical practice.
Programme
Master's Award: Canada Graduate Scholarships
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
349872
Name
Lee Lik Hang Nicholas
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Patterns of antipsychotic utilization in individuals with treatment-resistant psychosis
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Antipsychotic Polypharmacy; Antipsychotics; Clinical Outcomes; Clinical Practice Guidelines; Clozapine; Drug Utilization; Functional Outcomes; Treatment-Resistant Psychosis
Abstract
Antipsychotics are commonly prescribed for the treatment of schizophrenia and other psychotic disorders. Unfortunately, adequate trials of these drugs are not always effective in alleviating symptoms. This is problematic because the remission of psychosis is necessary for recovery. Therefore, the optimization of existing treatments is the first step towards improving the quality of life in individuals with treatment-resistant psychosis.Clozapine is the most effective antipsychotic in treatment-resistant psychosis. However, some of its adverse effects have contributed to its underutilization in clinical practice. Other treatment strategies are commonly used despite their lack of evidence. Suffice it to say, the management of treatment-resistant psychosis is a challenging endeavor that is all too often based on clinical experience rather than empirical evidence.The proposed research looks to build upon existing evidence in the pharmacological management of treatment-resistant psychosis. Thus, the objectives are 1) to characterize the patterns of antipsychotic utilization on admission to and discharge from the BC Psychosis Program, 2) to investigate the outcomes associated with the different patterns of antipsychotic utilization, and 3) to determine if these patterns and outcomes differ with the sex and diagnosis of the treated individual. The hope is that these findings will inform future research and clinical practice.
Competitiondate
201512
Approvedterm2
1 yr 0 mth
Pinamesdelim
Lee, Lik Hang Nicholas
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~